Cite
HARVARD Citation
Koskenvesa, P. et al. (n.d.). Imatinib and pegylated IFN‐α2b discontinuation in first‐line chronic myeloid leukemia patients following a major molecular response. European journal of haematology. pp. 413-420. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Koskenvesa, P. et al. (n.d.). Imatinib and pegylated IFN‐α2b discontinuation in first‐line chronic myeloid leukemia patients following a major molecular response. European journal of haematology. pp. 413-420. [Online].